INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 422
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 27,370 | $9.50 | 89,035 |
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 422
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 27,370 | -- | -- |
| Oct 01, 2013 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 27,475 | $111.01 | 69,562 |
| Oct 01, 2013 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 27,475 | -- | 1,801 |
| Feb 14, 2012 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 27,475 | $111.01 | 363,204 |
| Feb 14, 2012 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,475 | -- | 29,276 |
| Dec 09, 2020 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,680 | -- | 27,680 |
| Mar 21, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 27,688 | $323.32 | 18,389,916 |
| Jan 05, 2012 |
Director, EVP, CSO & Pres, REGN Res Labs
Trans History: 628
|
Director, EVP, CSO & Pres, REGN Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 27,713 | $58.00 | 833,041 |
| May 14, 2021 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 27,775 | $516.69 | 36,505 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.